Primate research center plays key role in HIV study in Nature

July 23, 2014 by Lisa Newbern

In a study reported in Nature this month, Yerkes National Primate Research Center researchers were key in determining that treating SIV-infected rhesus macaques with type 1 interferon, a protein known to trigger antiviral responses and inflammation, can have beneficial and detrimental effects on the development of disease.

The Yerkes researchers used high-tech RNA-sequencing technology to study genome-wide expression (transcriptome) of antiviral responses in monkey tissues during various stages of the study. This work was critical to determining that blocking interferon at the onset of infection may be a viable strategy for treating HIV-related disease, but equally important is giving consideration to the viral status of each patient because interferon blockade may trigger a rebound in virus levels in chronic infection.

Steve Bosinger, PhD, a Yerkes researcher, co-director of the Yerkes Nonhuman Primate Genomics Core and a study co-author, says, "Using genomic technology was critical to the study because the interferon system works by inducing hundreds of different antiviral genes. Genomics, rather than single-gene approaches, is needed to adequately assess the viability of the treatment blockade. Using genomics allowed us to identify novel pathways that were perturbed by blocking interferon signaling."

To do this, the researchers used a new version of the genome that has three times the number of annotated genes than what has been available.

Interferon is the central, crucial component of an innate immune response against viruses. Most viral infections are cleared or are controlled in a few weeks and the interferon response stops. In HIV/SIV, however, the infection persists indefinitely, and the interferon response goes on as well. Because of this, scientists have speculated for years that interferon itself may be a significant contributor to disease in people infected with HIV. In the Nature study, the researchers tested this directly by giving interferon to one group of monkeys and administering an inhibitor in a second group of animals.

The study's lead authors are Daniel Douek, MD, PhD, Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, and Netanya Sandler, MD, Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical Branch at Galveston. Robert Norgren, PhD, Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, provided the rhesus genome reference. Greg Tharp, Msc, a bioinformaticist in the Yerkes Nonhuman Primate Genomics Core, also contributed to the study. Bosinger says the Yerkes Core will perform the genomics components of Douek's follow-up studies, which will examine the effect of blockade on chronic infection and in animals receiving anti-retroviral therapy.

Explore further: Researchers find interferon has both detrimental and beneficial effects on SIV infected rhesus macaques

Related Stories

Researchers find interferon has both detrimental and beneficial effects on SIV infected rhesus macaques

July 10, 2014
(Medical Xpress)—A large team of researchers with affiliations to several facilities in the U.S. and Israel has found that administering Type 1 interferon to rhesus macaques infected with Simian Immunodeficiency Virus (SIV) ...

Predicting the outcome of hepatitis C virus treatment

July 1, 2014
Millions of people throughout the world are infected with hepatitis C virus (HCV), which can lead to cirrhosis of the liver and cancer. Directly acting antiviral agents inhibit viral proteins and have been used to successfully ...

Which interferons best control viral infections?

June 26, 2014
Respiratory and intestinal infections caused by RNA viruses stimulate infected cells to produce interferons, which can act alone or in combination to block virus replication. Important differences between the presence of ...

Scientists find new way to mobilize immune system against viruses

May 12, 2014
University of British Columbia scientists have uncovered an intricate chain reaction in the body's immune system and have used the knowledge to develop a new treatment against harmful viruses.

Scientists discover effects of PD-1 blockade on ART therapy in SIV-infected monkeys

March 8, 2012
Scientists have discovered that blocking PD-1 (programmed death-1), an immune molecule that inhibits the immune response to viral infections, can have a significant effect on HIV-like illness in nonhuman primates.

Mammals defend against viruses differently than invertebrates

June 23, 2014
Biologists have long wondered if mammals share the elegant system used by insects, bacteria and other invertebrates to defend against viral infection. Two back-to-back studies in the journal Science last year said the answer ...

Recommended for you

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

A sodium surprise: Engineers find unexpected result during cardiac research

July 20, 2017
Irregular heartbeat—or arrhythmia—can have sudden and often fatal consequences. A biomedical engineering team at Washington University in St. Louis examining molecular behavior in cardiac tissue recently made a surprising ...

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.